HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance

HER2/neutesting for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

(2012) Carlos Gómez-Martin et al.   JOURNAL OF CLINICAL PATHOLOGY

HER2 testing in gastric cancer: a practical approach

(2012) Josef Rüschoff et al.   MODERN PATHOLOGY

HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature

(2012) Jan Trøst Jørgensen et al.   Journal of Cancer

Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method

(2011) Elena García-García et al.   HISTOPATHOLOGY

Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma

(2010) Bettina G. Papouchado et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A study of HER2 gene amplification and protein expression in gastric cancer

(2010) B. Yan et al.   JOURNAL OF CLINICAL PATHOLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

(2009) I-Tien Yeh et al.   MODERN PATHOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY